EP4069237
TVÍVERKANDI EFNASAMBÖND TIL AÐ BRJÓTA BTK NIÐUR Í GEGNUM UBIQUITÍN PRÓTEASÓMFERLIÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.12.2020EP published:
9.4.2025EP application number:
20829249.0
EP translation filed:
25.6.2025Grant published:
15.7.2025EPO information:
European Patent Register
Max expiry date:
2.12.2040Expiry date:
2.12.2026Next due date:
31.12.2026
Title in English:
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAYLanguage of the patent:
English
Timeline
Today
3.12.2020EP application
9.4.2025EP Publication
25.6.2025Translation submitted
15.7.2025Registration published
2.12.2026Expires
Owner
Name:
Nurix Therapeutics, Inc.Address:
1700 Owens Street Suite 205, San Francisco, CA 94158, US
Inventor
Name:
SANDS, Arthur T.Address:
San Francisco, California 94158, US
Name:
KELLY, AileenAddress:
San Francisco, California 94158, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962943720 PDate:
4.12.2019Country:
US
Number:
202063010524 PDate:
15.4.2020Country:
US
Classification
Categories:
A61K 31/497, A61K 31/5377, A61P 35/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.12.2025
Expires: 2.12.2026
Payer: Árnason Faktor ehf.